TipRanks
Go Ultimate55% OFF

Annexin Pharmaceuticals AB (ANNX) Cash flow

Annexin Pharmaceuticals AB Cash Flow

SE:ANNX's free cash flow for Q3 2026 was $-9.95M. For the 2026 fiscal year, SE:ANNX's free cash flow was increased by $0.00 and operating cash flow was $-9.95M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -36.92M$ -50.23M$ -43.40M$ -41.16M$ -45.02M
$ -129.00K$ 0.00$ 96.00K$ -260.00K$ 0.00
$ 48.11M$ 45.15M$ 33.61M$ 23.06M$ 76.37M
$ 27.39M$ 16.34M$ 21.41M$ 31.11M$ 49.48M
$ -37.05M$ -50.23M$ -43.40M$ -41.16M$ -45.02M

Currency in SEK

Annexin Pharmaceuticals AB Cash Flow

-75M-50M-25M025M50M75M100M201720182019202020212022202320242025OperatingInvestingFinancing